Board-Led Initiative Aims to Accelerate Revenue Growth and Expand Government Contract Access Following Growing Momentum in Defense Sector Committee Is Evaluating Targets Offering Contract Vehicles, Past Performance, and Synergistic Capabilities AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) — Virtuix Holdings Inc. (NASDAQ: VTIX), a leading developer of full-body virtual reality (VR) systems, today announced that its Board of Directors has formed a special committee to evaluate potential acquisitions in the defense training and simulation industry. The committee is actively reviewing multiple acquisition opportunities, including targets in advanced-stage discussions, with a focus on companies that provide immediate access to government contract vehicles and recurring defense revenues in the $10M-$50M range. The initiative reflects...

Customer advances from sample testing to serial orders, reinforcing confidence in Maris-Tech’s technology by the global defense market Rehovot, Israel, May 07, 2026 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and artificial intelligence (“AI”)- based edge computing technology, today announced that it has received its first serial production order through a distributor for an end customer in Singapore’s defense sector. The order follows a comprehensive evaluation process of Maris-Tech’s products. The customer initially procured product samples, which underwent comprehensive testing and assessment. Following this evaluation phase, the customer transitioned from sample orders to serial production purchases. “We believe that this transition from sample evaluation...

Leadership includes Validated Technology, Scalable Production Momentum, and Relentless R&D Execution DENVER, May 07, 2026 (GLOBE NEWSWIRE) — (www.247marketnews.com) – In a sector filled with bold claims but limited real-world execution, Kraig Biocraft Laboratories (OTCQB: KBLB) is emerging as a serious contender in the global race to commercialize spider silk, backed not just by promise, but by validated science and advancing production capability. The race to commercialize spider silk, a material long hailed as one of the toughest and most versatile fibers on Earth, has attracted a wide field of innovators. At the center of this differentiation is the company’s focus on technology validation, a critical hurdle in a sector where many competitors remain in early-stage development or confined to laboratory-scale proof of...

NEWARK, Calif., May 07, 2026 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, announced today that members of its senior management team will participate in several upcoming investor conferences:20th Annual Needham Technology & Media Conference – on Thursday, May 14, 2026, Concentrix will offer a company presentation with question and answer session from 8:45 a.m. – 9:25 a.m. ET and will host investor meetings during the virtual event. J.P. Morgan 2026 Global Technology, Media and Communications Conference – on Monday, May 18, 2026, at the Westin Boston Seaport Hotel in Boston, MA, Concentrix will participate in a fireside chat from 11:45 a.m. – 12:20 p.m. ET and host investor meetings. 20th Annual Barrington Research Virtual Spring Investment Conference – on Wednesday,...

US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark expansion of company’s coast–to–coast RLT manufacturing network – the largest in the US Expanded infrastructure brings highly personalized cancer therapies closer to patients across the southern US Denton groundbreaking is latest milestone in Novartis’ $23 billion investment in US research and manufacturingBasel, May 7, 2026 – Novartis, a leading global innovative medicines company, today broke ground on its new 46,000 sq. ft radioligand therapy (RLT) manufacturing site in Denton, Texas, the latest milestone in its broader $23 billion investment in US manufacturing and research. The start of construction on the company’s first Texas‑based manufacturing facility brings US RLT production closer to patients across...

US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark expansion of company’s coast–to–coast RLT manufacturing network – the largest in the USExpanded infrastructure brings highly personalized cancer therapies closer to patients across the southern USDenton groundbreaking is latest milestone in Novartis’ $23 billion investment in US research and manufacturingEast Hanover, May 7, 2026 – Novartis, a leading global innovative medicines company, today broke ground on its new 46,000 sq. ft radioligand therapy (RLT) manufacturing site in Denton, Texas, the latest milestone in its broader $23 billion investment in US manufacturing and research. The start of construction on the company’s first Texas‑based manufacturing facility brings US RLT production closer to patients...